Profile
David J.
Sekula is Chief Executive Officer & Executive Director at Global Tax Management, Inc. since 2006.
Former jobs include Principal at Smiths Group North America, Inc. and Principal at GlaxoSmithKline LLC.
Education includes undergraduate and graduate degrees from St. Joseph's University.
David Sekula active positions
| Companies | Position | Start |
|---|---|---|
Global Tax Management, Inc.
Global Tax Management, Inc. Other Consumer ServicesConsumer Services Provides corporate tax services | Chief Executive Officer | 2006-01-31 |
Former positions of David Sekula
| Companies | Position | End |
|---|---|---|
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | - |
Smiths Group North America, Inc.
Smiths Group North America, Inc. Aerospace & DefenseElectronic Technology Manufactures aircraft control systems, electronic, navigational systems and instruments | Corporate Officer/Principal | - |
Training of David Sekula
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
St. Joseph's University
St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Tax Management, Inc.
Global Tax Management, Inc. Other Consumer ServicesConsumer Services Provides corporate tax services | Consumer Services |
Smiths Group North America, Inc.
Smiths Group North America, Inc. Aerospace & DefenseElectronic Technology Manufactures aircraft control systems, electronic, navigational systems and instruments | Electronic Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
- Stock Market
- Insiders
- David Sekula
















